YY

Yau Yeung Joel Lau

Director Additional Director DIN 03544760
DIN 03544760 First appointment Jun 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Yau Yeung Joel Lau

Data last updated:

Yau Yeung Joel Lau was an Additional Director at Chiron Behring Vaccines Private Limited (2011–2014) and Nominee Director at Chiron Panacea Vaccines Private Limited (from 2011). The companies operate in Pharma.

DIN 03544760
Primary Designation Additional Director
Industry Pharma
First Appointment 14 Jun 2011
Oldest Company Age 22 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director14 Jun 20111997₹94.53 Cr (FY 2025)Active
Nominee Director07 Jul 20112004Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chiron Panacea Vaccines Private Limited
Chiron Behring Vaccines Private Limited
Premium access

Shareholding and investment profile for Yau Yeung Joel Lau

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yau Yeung Joel Lau

Yau Yeung Joel Lau was first appointed on 14 Jun 2011 as Additional Director at Chiron Behring Vaccines Private Limited.

Yau Yeung Joel Lau held 2 earlier board appointments: Chiron Behring Vaccines Private Limited (Additional Director, 14 Jun 2011 to 21 Mar 2014); Chiron Panacea Vaccines Private Limited (Nominee Director, from 07 Jul 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available